Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder

Name: Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
SKU: 24333
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 51 No. 3 Articles 2021 Tags: Alessandra Gasparini, Camilla Callegari, Giulia Lucca, Ivano Caselli, long-acting injectables, Marta Ielmini, Nicola Poloni, phenomenology, psychopathology, schizophrenia, Stefano Amorosi, subjectivity

Description

Description

Original Research

Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder

By Ivano Caselli, Alessandra Gasparini, Marta Ielmini, Giulia Lucca, Stefano Amorosi, Nicola Poloni, Camilla Callegari

Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder

Description

Original Research

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Gender and Schizophrenia

Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder

Description

Original Research

Related products

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Gender and Schizophrenia